Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca.
As part of the triad of Sjögren's syndrome (SS), keratoconjunctivitis sicca (KCS) can be found in virtually all SS patients. This term emphasizes not only the reduced tear production but also the pathologic changes in the epithelial cells of the ocular surface. The symptoms of dry eye may vary from one patient to another depending on the severity of dryness, the ability of the diminished tear film to moisten the ocular surface, and the patient's tolerance for ocular discomfort. Treatment of the dry eyes is remarkably effective, and most patients benefit from moisturizing eyedrops to replace their own deficient tears. Major issues include the pathogenesis of decreased tear flow and ocular surface disturbances, as well as the roles of wound healing agents and anti-inflammatory medications in KCS therapy.
Friedlaender
M H
MH
Division of Ophthalmology, Scripps Clinic and Research Foundation, La Jolla, California.
D006801:Humans; D007638:Keratoconjunctivitis Sicca / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D012859:Sjogren's Syndrome / Q000150:complications*